Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Bibtex

@article{02a33a5415d74c398f1813e8421fba4a,
title = "Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.",
abstract = "Tyrosine kinase inhibitors (TKIs) used in the treatment of chronic myeloid leukaemia have been reported to induce immunomodulatory effects. We aimed to assess peripheral blood (PB) and bone marrow (BM) lymphocyte status at the diagnosis and during different TKI therapies and correlate it with treatment responses.",
author = "{El Missiry}, Mohamed and {Adnan Awad}, Shady and Rajala, {Hanna L} and Ahmed Al-Samadi and Marja Ekblom and Berit Markev{\"a}n and Ingbritt {\AA}strand-Grundstr{\"o}m and Maren Wold and Svedahl, {Ellen Rabben} and Juhl, {Birgitte Ravn} and Bjerrum, {Ole Weis} and Inger Haulin and Kimmo Porkka and Ulla Olsson-Str{\"o}mberg and Henrik Hjorth-Hansen and Satu Mustjoki",
year = "2016",
doi = "10.1007/s00432-015-2101-4",
language = "English",
volume = "142",
pages = "1041--1050",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "1432-1335",
publisher = "Springer",
number = "5",

}